ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 77 filers reported holding ADAGIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,860,650 | -8.5% | 1,094,500 | -43.5% | 0.00% | 0.0% |
| Q2 2023 | $2,032,669 | +110914.1% | 1,935,875 | +26.8% | 0.00% | 0.0% |
| Q1 2023 | $1,831 | +0.8% | 1,526,159 | +26.0% | 0.00% | 0.0% |
| Q4 2022 | $1,817 | -99.9% | 1,211,099 | +143.8% | 0.00% | 0.0% |
| Q3 2022 | $1,555,000 | +396.8% | 496,697 | +420.1% | 0.00% | – |
| Q2 2022 | $313,000 | -58.0% | 95,499 | -7.1% | 0.00% | – |
| Q4 2021 | $746,000 | +165.5% | 102,781 | +1447.7% | 0.00% | – |
| Q3 2021 | $281,000 | – | 6,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $13,872,375 | 13.22% |
| Alphabet Inc. | 5,680,785 | $8,521,178 | 0.50% |
| 683 Capital Management, LLC | 3,000,000 | $4,500,001 | 0.38% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $2,906 | 0.32% |
| Slate Path Capital LP | 3,735,000 | $5,602,500 | 0.30% |
| Newtyn Management, LLC | 900,000 | $1,350,000 | 0.28% |
| Orbimed Advisors | 5,270,400 | $7,905,600 | 0.15% |
| Oasis Management Co Ltd. | 348,432 | $522,648 | 0.10% |
| Redmile Group, LLC | 1,440,725 | $2,161,088 | 0.09% |
| Anson Funds Management LP | 154,156 | $231,234 | 0.04% |